title: A baseline study of pediatric dialysis in Texas.
abstract: This study provides a cross-sectional view of the management of 94 Texas children with end-stage renal disease in 1996 and serves as a point of comparison for future changes in management practice. Data collected in 6 pediatric and 18 adult dialysis facilities in Texas revealed that a greater proportion of younger pediatric patients received peritoneal dialysis (PD). Patients on PD had a significantly lower serum albumin level than those on hemodialysis (HD). HD and PD patients were 2.3 and 1.7 standard deviation scores (SDS) below the average height of the age- and gender-matched populations, respectively. There was no significant difference in hematocrit, use of growth hormone, parathyroid hormone level, weight SDS, or bone age by treatment modality. However, patients dialyzed in pediatric facilities were more likely to receive growth hormone and to be regularly evaluated for Tanner stage and bone age than those in adult facilities. Measurement of creatinine clearance as a measure of adequacy of PD in young children was not a common practice. Instead pediatric nephrologists tended to rely more on anthropometric measurements, developmental maturation, and serum albumin to assess adequacy. Opportunities remain to maximize the growth potential and to develop standards for the adequacy of dialysis in the younger patient.
authors.affiliation: Health Management Program, School of Business, Quinnipiac University, 275 Mount Carmel Avenue, Hamden, CT 06518, USA. teresa.tai@quinnipiac.edu
authors.forename: T W
authors.initials: TW
authors.lastname: Tai
authors.forename: A
authors.initials: A
authors.lastname: Kalia
mesh_terms: D000293:Adolescent; D000328:Adult; D001846:Bone Development; D002648:Child; D002675:Child, Preschool; D003404:Creatinine / Q000378:metabolism; D003430:Cross-Sectional Studies; D005006:Ethnicity; D005260:Female; D006128:Growth; D006268:Health Facilities; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000208:ethnology / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D010281:Parathyroid Hormone / Q000097:blood; D010530:Peritoneal Dialysis; D006435:Renal Dialysis; D012709:Serum Albumin / Q000032:analysis; D012741:Sexual Maturation; D013781:Texas; D013997:Time Factors; D016896:Treatment Outcome; D014508:Urea / Q000378:metabolism
chemical_list: D010281:Parathyroid Hormone; D012709:Serum Albumin; D014508:Urea; D003404:Creatinine